Cite
HARVARD Citation
Reau, N. et al. (2017). Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir: A pooled analysis of 1, 322 patients with hepatitis C infection. Hepatology communications. 1 (8), pp. 757-764. [Online].